Search results
Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. Subscribe on YouTube. Sun Pharma Story.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
3 days ago · Sun Pharmaceutical Industries Limited Stock Price Today, Live NSE Share Price: Get the latest Sun Pharmaceutical Industries Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active...
Get all the information on Sun Pharma with historic price charts for NSE / BSE. Experts & Broker view also get the Sun Pharma Ltd. buy/sell tips detailed news, announcements, Forecasts,...
Jun 24, 2024 · Sun Pharma Industries on Monday said it has completed the merger of Taro Pharmaceutical Industries with itself in a deal valued at $347.73 million. As part of the merger, Sun Pharma has ...
Jun 24, 2024 · It is noteworthy that Taro had net sales of US$ 629 million in FY2023-24 and cash of $1.3 billion (as of March 31, 2024). On May 26, 2023, Sun Pharma issued a letter to the Board of Directors of ...
1 day ago · Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharmaceutical Industries, including: Last traded price 1529.0, Market capitalization: 366738.35, Volume: 840140, Price-to-earnings ratio 38.32, Earnings per share 39.91. Get a complete picture of Sun Pharmaceutical Industries's performance through our comprehensive blend of fundamental and ...
